Cyclerion Therapeutics【CYCN】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

3.3998

買値

1.65

売値

4.78

出来高

267,101

2.8345 日の範囲 3.43

1.27 52 週間の範囲 9.4699

時価総額

9.214M

前日終値

2.95

始値

3.3999

時刻

3.35

最終取引時間

財務取引量

US$ 836,820

VWAP

3.133

平均取引量 (3 か月)

3,256,077

発行済株式数

2,710,096

配当利回り

PER

-1.64

1 株当たり利益 (EPS)

-1.94

歳入

純利益

-5.26M

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of nex... Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.cyclerion.com

本社

Boston, Massachusetts, USA

設立

Cyclerion Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker CYCN. The last closing price for Cyclerion Therapeutics was US$2.95. Over the last year, Cyclerion Therapeutics shares have traded in a share price range of US$ 1.27 to US$ 9.4699.

Cyclerion Therapeutics currently has 2,710,096 shares in issue. The market capitalisation of Cyclerion Therapeutics is US$7.99 million. Cyclerion Therapeutics has a price to earnings ratio (PE ratio) of -1.64.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0702	-2.02305475504	3.47	3.79	2.8	241277	3.07120818	CS
4	1.9798	139.422535211	1.42	9.4699	1.27	9053661	5.52352959	CS
12	0.7098	26.3866171004	2.69	9.4699	1.27	3256077	5.30245818	CS
26	1.2098	55.2420091324	2.19	9.4699	1.27	1529635	5.29728817	CS
52	-1.4802	-30.3319672131	4.88	9.4699	1.27	778411	5.29351876	CS
156	-32.4002	-90.5033519553	35.8	37.8	1.27	362344	7.87088367	CS
260	-40.6002	-92.2731818182	44	179.2	1.27	452401	42.35496776	CS

CYCN - Frequently Asked Questions (FAQ)

What is the current Cyclerion Therapeutics share price?

The current share price of Cyclerion Therapeutics is US$ 3.3998

How many Cyclerion Therapeutics shares are in issue?

Cyclerion Therapeutics has 2,710,096 shares in issue

What is the market cap of Cyclerion Therapeutics?

The market capitalisation of Cyclerion Therapeutics is USD 7.99M

What is the 1 year trading range for Cyclerion Therapeutics share price?

Cyclerion Therapeutics has traded in the range of US$ 1.27 to US$ 9.4699 during the past year

What is the PE ratio of Cyclerion Therapeutics?

The price to earnings ratio of Cyclerion Therapeutics is -1.64

What is the reporting currency for Cyclerion Therapeutics?

Cyclerion Therapeutics reports financial results in USD

What is the latest annual profit for Cyclerion Therapeutics?

The latest annual profit of Cyclerion Therapeutics is USD -5.26M

What is the registered address of Cyclerion Therapeutics?

The registered address for Cyclerion Therapeutics is 155 FEDERAL STREET, SUITE 700, BOSTON, MASSACHUSETTS, 02110

What is the Cyclerion Therapeutics website address?

The website address for Cyclerion Therapeutics is www.cyclerion.com

Which industry sector does Cyclerion Therapeutics operate in?

Cyclerion Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.5M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.63M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.84M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	8.58M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	5.96M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M